Cryogenic OGS, a Maharashtra-based company specializing in cryogenic oxygen and gas systems, is set to list its IPO on the SME platform of the Bombay Stock Exchange (BSE) on July 10, 2025, after its public offering was oversubscribed by a massive 646 times. The IPO allotment status can now be checked through the registrar, Link Intime India Pvt Ltd, and also via the BSE official portal. The grey market premium (GMP) signals a potential listing gain of over 68 percent.
Cryogenic OGS, a Maharashtra-based company engaged in manufacturing cryogenic oxygen and gas systems, is preparing to debut its shares on the SME platform of the Bombay Stock Exchange (BSE) on July 10, 2025. This follows a massive response to its Rs 17.77 crore Initial Public Offering (IPO), which was oversubscribed 646 times in the primary market between July 3 and 7.
The IPO was launched with a price band of ₹44–₹47 per share, and the allotment status was made live on July 8, 2025, by the issue’s registrar, Link Intime India Pvt Ltd, a prominent IPO registrar headquartered in Mumbai.
How to Check Cryogenic OGS IPO Allotment Status
Investors can check their allotment status by following these steps:
Via Registrar (Link Intime)
- Visit Link Intime IPO Allotment Portal
- Select “Cryogenic OGS” from the dropdown
- Enter PAN/Application Number/DP ID
- Click on “Submit”
Via BSE Website
- Go to BSE’s Application Status Page
- Click on “Investors” > “Status of Issue Application”
- Select Equity > Cryogenic OGS
- Enter your PAN and application details
- Click “Search” to view status
Grey Market Premium Indicates 68% Listing Gain
According to IPO tracking platforms, Cryogenic OGS shares are trading at a ₹32 grey market premium (GMP), implying a 68.09% expected listing gain over the upper price band.
The company is set to make a strong debut on the SME platform of BSE as retail and institutional investor sentiment remains highly optimistic.
Stay tuned for the official listing on July 10, 2025, to see how the Cryogenic OGS stock performs in the public market.

